Chief Executive Officer
B.Bus. (Hons.)(ECU), LL.M. (Bond),
J.P. (Qual.)(Qld.), Grad. Cert. Legal Practice, Grad. Cert. Continuing Legal Practice (UTS), GCTM (Biotechnology), GDipBiotech (UQ) AFAIM, FAICD, SIA (Aff)
Damien Millen is the CEO of pharmaBank Pty Ltd.  His commercial experience and interest encompasses the development and implementation of corporate strategies for start-up companies. This includes project sourcing, venture capital initiation, IPO development, technology transfer and intellectual property licensing. Prior to his role with pharmaBank, Damien practiced in antitrust, company and intellectual property law in Queensland and New South Wales in addition to serving other corporate counsel roles in Victoria and overseas.  In addition to his commercial activities he contributes regularly to scholarly journals and teaches and researches in areas related to the biotechnology sector. He is also an adjunct Associate Professor of Law at Bond University.